ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,472,943 | -91.9% | 164,810 | -90.9% | 0.01% | -91.7% |
| Q2 2023 | $55,535,530 | +129.2% | 1,806,621 | +168.6% | 0.11% | +111.8% |
| Q1 2023 | $24,231,256 | +39.5% | 672,530 | +55.6% | 0.05% | +34.2% |
| Q3 2022 | $17,368,000 | +496.8% | 432,250 | +479.0% | 0.04% | +533.3% |
| Q1 2022 | $2,910,000 | -61.7% | 74,655 | -60.9% | 0.01% | -57.1% |
| Q4 2021 | $7,605,000 | -82.5% | 190,846 | -84.1% | 0.01% | -92.2% |
| Q3 2021 | $43,440,000 | +3428.8% | 1,201,980 | +4008.6% | 0.18% | +2150.0% |
| Q3 2020 | $1,231,000 | – | 29,255 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |